Fda Approved - Search News

FDA red food dye ban

FDA bans Red Dye No. 3, artificial coloring used in beverages, candy and other foods

The Food and Drug Administration said Wednesday it’s banning the use of Red No. 3, a synthetic dye that gives food and drinks their bright red cherry color but has been linked to cancer in animals.

USA TODAY on MSN · 6h

FDA bans Red No. 3 food dye in food, drinks: Here's what to know

The FDA announced on Wednesday that it has banned the use of Red No. 3, an additive used to give food and drinks a cherry-red color.

Forbes · 10h

FDA Bans Red No. 3, Leaving 8 Synthetic Dyes In America’s Food

With Wednesday's ban of Red No. 3, there are now 8 artificial dyes in America's food supply. Discover what dyes remain, the health risk to humans, and the companies involved.

FDA Approves Niktimvo 9 Mg And 22 Mg Vial Sizes

The Wall Street Journal on MSN · 8h

Eli Lilly Receives FDA Approval for Crohn’s Disease Treatment

Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s disease, an inflammatory bowel disease that causes chronic abdominal pain.

MarketWatch · 7h

Incyte's and Syndax's Graft Disease Treatment Niktimvo Gets FDA Approval for Vial Sizes

Incyte has exclusive commercialization rights for Niktimvo outside the U.S. Niktimvo was approved by the FDA on Aug. 14 for the treatment of chronic graft-versus-host disease after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kilograms.

Seeking Alpha on MSN · 6h

Incyte, Syndax get FDA okay for 9 mg, 22 mg Niktimvo vials

Incyte (NASDAQ:INCY) and Syndax Pharmaceuticals (SNDX) have received FDA approval for their drug Niktimvo in 9 mg and 22 mg vial sizes. Niktimvo was approved in August 2024 for the treatment of chronic graft-versus-host disease after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg,

3hon MSN

US FDA approves expanded use of Lilly's bowel disease drug

Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...

STAT1d

Federal watchdog raises some concerns about the FDA’s accelerated approval program

The Office of Inspector General reviewed the FDA’s use of accelerated approval for 24 drugs, ultimately finding issues with ...

BioPharma Dive13h

Federal watchdog cites concerns with FDA’s accelerated approval process

The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...

Becker's Hospital Review6h

Watchdog flags flaws in FDA's fast-track drug approvals

The OIG report points to gaps in documentation and decision-making transparency, particularly in the case of Aduhelm, where FDA records indicated only 13 meetings with Biogen, but congressional ...

16h

BridgeBio Pharma Is A Buy On Dips After Attruby's FDA Approval

Attruby's approval makes BridgeBio Pharma a competitor to Vyndaqel, with significant potential for growth and milestone ...

FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

2don MSN

Billed as nonaddictive, new pain pill could soon win FDA approval

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

Cure Today7h

The Subcutaneous Approval of Opdivo Makes Waves in Future of Cancer Care

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA red food dye ban

FDA Approves Niktimvo 9 Mg And 22 Mg Vial Sizes

Related topics